Literature DB >> 11427339

Elevation of guinea pig brain preprodynorphin mRNA expression and hypothalamic-pituitary-adrenal axis activity by "binge" pattern cocaine administration.

V Yuferov1, Y Zhou, K S LaForge, R Spangler, A Ho, M J Kreek.   

Abstract

The endogenous opioid system and the hypothalamic-pituitary-adrenal (HPA) axis have been implicated in many of the neurobiological effects of cocaine. Previous studies in our laboratory showed that "binge" pattern cocaine administration increases preprodynorphin (ppDyn) mRNA levels in the caudate putamen and circulating levels of corticosterone in the rat. The present study extended these findings to guinea pigs, a species known to have a kappa opioid receptor profile similar to that of humans. Male guinea pigs were treated with: (a) "binge" pattern cocaine for 7 days (subchronic) (3 x 15 mg/kg/day, hourly, intraperitoneal); (b) "binge" pattern saline for 5 days followed by "binge" pattern cocaine for 2 days (subacute); or (c) "binge" pattern saline for 7 days. Thirty minutes after the final injection, levels of ppDyn mRNA were quantitated in the nucleus accumbens, caudate putamen, frontal cortex, amygdala, hippocampus, and hypothalamus using a solution hybridization RNase protection assay. Regional distribution of ppDyn mRNA levels in the guinea pig brain was similar to that found in rat, with highest levels in the nucleus accumbens and caudate putamen. In the caudate putamen, ppDyn mRNA was significantly increased following either 2 days (38% increase) or 7 days (32% increase) of "binge" pattern cocaine administration as compared to saline-treated controls. No significant changes in ppDyn mRNA levels were found in any other brain region. Both subacute and subchronic "binge" cocaine administration significantly elevated plasma levels of adrenocorticotropin hormone (ACTH) and cortisol. However, the ACTH and cortisol increases were significantly blunted following 7 days of "binge" cocaine administration as compared to 2 days of drug treatment, reflecting the development of HPA tolerance or adaptation to repeated cocaine administration. Thus, the ppDyn mRNA and HPA responses to cocaine in guinea pigs are similar to those observed in rats.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11427339     DOI: 10.1016/s0361-9230(01)00496-8

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  12 in total

1.  Effect of the endogenous kappa opioid agonist dynorphin A(1-17) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice.

Authors:  Yong Zhang; Eduardo R Butelman; Stefan D Schlussman; Ann Ho; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2004-01-08       Impact factor: 4.530

Review 2.  Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment.

Authors:  Vadim Yuferov; Orna Levran; Dmitri Proudnikov; David A Nielsen; Mary Jeanne Kreek
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

Review 3.  The endogenous opioid system in cocaine addiction: what lessons have opioid peptide and receptor knockout mice taught us?

Authors:  Ji Hoon Yoo; Ian Kitchen; Alexis Bailey
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

4.  Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning.

Authors:  Jay P McLaughlin; Benjamin B Land; Shuang Li; John E Pintar; Charles Chavkin
Journal:  Neuropsychopharmacology       Date:  2006-04       Impact factor: 7.853

5.  Effects of the mixed mu/kappa opioid nalbuphine on cocaine-induced changes in subjective and cardiovascular responses in men.

Authors:  Nancy K Mello; Jack H Mendelson; Michelle B Sholar; Maria Jaszyna-Gasior; Nathalie Goletiani; Arthur J Siegel
Journal:  Neuropsychopharmacology       Date:  2005-03       Impact factor: 7.853

6.  Tissue-specific DNA methylation of the human prodynorphin gene in post-mortem brain tissues and PBMCs.

Authors:  Vadim Yuferov; David A Nielsen; Orna Levran; Matthew Randesi; Sara Hamon; Ann Ho; Susan Morgello; Mary Jeanne Kreek
Journal:  Pharmacogenet Genomics       Date:  2011-04       Impact factor: 2.089

7.  Chromatin alterations in response to forced swimming underlie increased prodynorphin transcription.

Authors:  B Reed; N Fang; B Mayer-Blackwell; S Chen; V Yuferov; Y Zhou; M J Kreek
Journal:  Neuroscience       Date:  2012-06-12       Impact factor: 3.590

Review 8.  Reward processing by the opioid system in the brain.

Authors:  Julie Le Merrer; Jérôme A J Becker; Katia Befort; Brigitte L Kieffer
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

9.  A functional haplotype implicated in vulnerability to develop cocaine dependence is associated with reduced PDYN expression in human brain.

Authors:  Vadim Yuferov; Fei Ji; David A Nielsen; Orna Levran; Ann Ho; Susan Morgello; Ruijin Shi; Jurg Ott; Mary Jeanne Kreek
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853

10.  Hippocampal dynorphin immunoreactivity increases in response to gonadal steroids and is positioned for direct modulation by ovarian steroid receptors.

Authors:  A Torres-Reveron; S Khalid; T J Williams; E M Waters; L Jacome; V N Luine; C T Drake; B S McEwen; T A Milner
Journal:  Neuroscience       Date:  2008-12-24       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.